• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小分子补充剂通过调节多个细胞周期调控因子改善培养巨核细胞的多倍体化。

Small Molecule Supplements Improve Cultured Megakaryocyte Polyploidization by Modulating Multiple Cell Cycle Regulators.

机构信息

Stem Cell and Regenerative Medicine Lab, Beijing Institute of Transfusion Medicine, Beijing 100850, China.

South China Research Center for Stem Cell & Regenerative Medicine, Guangzhou 510005, China.

出版信息

Biomed Res Int. 2017;2017:2320519. doi: 10.1155/2017/2320519. Epub 2017 Oct 19.

DOI:10.1155/2017/2320519
PMID:29201898
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5671672/
Abstract

Platelets (PLTs) are produced by megakaryocytes (MKs) that completed differentiation and endomitosis. Endomitosis is an important process in which the cell replicates its DNA without cytokinesis and develops highly polyploid MK. In this study, to gain a better PLTs production, four small molecules (Rho-Rock inhibitor (RRI), nicotinamide (NIC), Src inhibitor (SI), and Aurora B inhibitor (ABI)) and their combinations were surveyed as MK culture supplements for promoting polyploidization. Three leukemia cell lines as well as primary mononuclear cells were chosen in the function and mechanism studies of the small molecules. In an optimal culture method, cells were treated with different small molecules and their combinations. The impact of the small molecules on megakaryocytic surface marker expression, polyploidy, proliferation, and apoptosis was examined for the best MK polyploidization supplement. The elaborate analysis confirmed that the combination of SI and RRI together with our MK induction system might result in efficient ploidy promotion. Our experiments demonstrated that, besides direct downregulation on the expression of cytoskeleton protein actin, SI and RRI could significantly enhance the level of cyclins through the suppression of p53 and p21. The verified small molecule combination might be further used in the in vitro PLT manufacture and clinical applications.

摘要

血小板(PLTs)由已完成分化和内有丝分裂的巨核细胞(MKs)产生。内有丝分裂是一个重要的过程,在此过程中,细胞在没有细胞分裂的情况下复制其 DNA,并发育成高度多倍体的 MK。在这项研究中,为了获得更好的 PLTs 产量,研究人员调查了四种小分子(Rho-Rock 抑制剂(RRI)、烟酰胺(NIC)、Src 抑制剂(SI)和 Aurora B 抑制剂(ABI))及其组合作为促进多倍体化的 MK 培养补充剂。在小分子的功能和机制研究中,选择了三种白血病细胞系和原代单核细胞。在最佳培养方法中,用不同的小分子及其组合处理细胞。研究了小分子对巨核细胞表面标记物表达、多倍性、增殖和凋亡的影响,以确定最佳的 MK 多倍体化补充剂。详细分析证实,SI 和 RRI 的组合与我们的 MK 诱导系统一起可能导致有效的倍性促进。我们的实验表明,除了直接下调细胞骨架蛋白肌动蛋白的表达外,SI 和 RRI 还可以通过抑制 p53 和 p21 显著提高细胞周期蛋白的水平。经过验证的小分子组合可能进一步用于体外 PLT 制造和临床应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc4b/5671672/45c33cd17066/BMRI2017-2320519.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc4b/5671672/a554616c3ab1/BMRI2017-2320519.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc4b/5671672/4b9a282eb86d/BMRI2017-2320519.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc4b/5671672/94c402927a6b/BMRI2017-2320519.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc4b/5671672/45c33cd17066/BMRI2017-2320519.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc4b/5671672/a554616c3ab1/BMRI2017-2320519.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc4b/5671672/4b9a282eb86d/BMRI2017-2320519.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc4b/5671672/94c402927a6b/BMRI2017-2320519.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc4b/5671672/45c33cd17066/BMRI2017-2320519.004.jpg

相似文献

1
Small Molecule Supplements Improve Cultured Megakaryocyte Polyploidization by Modulating Multiple Cell Cycle Regulators.小分子补充剂通过调节多个细胞周期调控因子改善培养巨核细胞的多倍体化。
Biomed Res Int. 2017;2017:2320519. doi: 10.1155/2017/2320519. Epub 2017 Oct 19.
2
Optimizing megakaryocyte polyploidization by targeting multiple pathways of cytokinesis.通过靶向细胞分裂的多个途径优化巨核细胞多倍体化。
Transfusion. 2012 Nov;52(11):2406-13. doi: 10.1111/j.1537-2995.2012.03711.x. Epub 2012 May 21.
3
Mechanistic studies on the effects of nicotinamide on megakaryocytic polyploidization and the roles of NAD+ levels and SIRT inhibition.烟酰胺对巨核细胞多倍体化影响的机制研究以及NAD +水平和SIRT抑制的作用
Exp Hematol. 2009 Nov;37(11):1340-1352.e3. doi: 10.1016/j.exphem.2009.08.004. Epub 2009 Aug 26.
4
Aurora B is dispensable for megakaryocyte polyploidization, but contributes to the endomitotic process.极光 B 对于巨核细胞的多倍体化是可有可无的,但有助于有丝分裂过程。
Blood. 2010 Sep 30;116(13):2345-55. doi: 10.1182/blood-2010-01-265785. Epub 2010 Jun 14.
5
Induction of polyploidization in leukemic cell lines and primary bone marrow by Src kinase inhibitor SU6656.Src激酶抑制剂SU6656诱导白血病细胞系和原代骨髓细胞多倍体化
Blood. 2005 May 15;105(10):3875-8. doi: 10.1182/blood-2004-10-3934. Epub 2005 Jan 27.
6
Uncoupling of the Hippo and Rho pathways allows megakaryocytes to escape the tetraploid checkpoint.河马通路和Rho通路的解偶联使巨核细胞能够逃避四倍体检查点。
Haematologica. 2016 Dec;101(12):1469-1478. doi: 10.3324/haematol.2016.149914. Epub 2016 Aug 11.
7
Aberrant quantity and localization of Aurora-B/AIM-1 and survivin during megakaryocyte polyploidization and the consequences of Aurora-B/AIM-1-deregulated expression.巨核细胞多倍体化过程中极光激酶B/AIM-1和生存素的异常数量与定位以及极光激酶B/AIM-1表达失调的后果
Blood. 2004 May 15;103(10):3717-26. doi: 10.1182/blood-2003-09-3365. Epub 2004 Jan 29.
8
miRNAs can increase the efficiency of ex vivo platelet generation.miRNAs 可以提高体外血小板生成的效率。
Ann Hematol. 2012 Nov;91(11):1673-84. doi: 10.1007/s00277-012-1517-z. Epub 2012 Jul 5.
9
miR-125b modulates megakaryocyte maturation by targeting the cell-cycle inhibitor p19.微小RNA-125b通过靶向细胞周期抑制剂p19来调节巨核细胞成熟。
Cell Death Dis. 2016 Oct 20;7(10):e2430. doi: 10.1038/cddis.2016.288.
10
Significance of AZD1152 as a potential treatment against Aurora B overexpression in acute promyelocytic leukemia.AZD1152作为急性早幼粒细胞白血病中极光激酶B过表达的潜在治疗方法的意义。
Ann Hematol. 2016 Jun;95(7):1031-42. doi: 10.1007/s00277-016-2670-6. Epub 2016 Apr 19.

引用本文的文献

1
RHOB regulates megakaryocytic and erythroid differentiation by altering the cell cycle and cytoskeleton.RHOB通过改变细胞周期和细胞骨架来调节巨核细胞和红细胞的分化。
Sci Rep. 2025 Apr 16;15(1):13159. doi: 10.1038/s41598-025-95946-3.
2
The Involvement of Canonical NFκB Pathway in Megakaryocyte Differentiation Induction by Nanocurcumin.经典NFκB信号通路在纳米姜黄素诱导巨核细胞分化中的作用
Int J Hematol Oncol Stem Cell Res. 2023 Jan 1;17(1):18-27. doi: 10.18502/ijhoscr.v17i1.11709.
3
Proteomics reveals the function reverse of MPSSS-treated prostate cancer-associated fibroblasts to suppress PC-3 cell viability via the FoxO pathway.

本文引用的文献

1
ROCK inhibitor reduces Myc-induced apoptosis and mediates immortalization of human keratinocytes.ROCK抑制剂可减少Myc诱导的细胞凋亡,并介导人角质形成细胞的永生化。
Oncotarget. 2016 Oct 11;7(41):66740-66753. doi: 10.18632/oncotarget.11458.
2
Genomic landscape of megakaryopoiesis and platelet function defects.巨核细胞生成和血小板功能缺陷的基因组格局
Blood. 2016 Mar 10;127(10):1249-59. doi: 10.1182/blood-2015-07-607952. Epub 2016 Jan 19.
3
Novel Insights into the Roles of Rho Kinase in Cancer.对Rho激酶在癌症中作用的新见解。
蛋白质组学揭示了 MPSSS 处理的前列腺癌相关成纤维细胞的功能逆转,通过 FoxO 通路抑制 PC-3 细胞活力。
Cancer Med. 2021 Apr;10(7):2509-2522. doi: 10.1002/cam4.3825. Epub 2021 Mar 11.
4
The (Patho)Biology of SRC Kinase in Platelets and Megakaryocytes.血小板和巨核细胞中SRC激酶的(病理)生物学
Medicina (Kaunas). 2020 Nov 24;56(12):633. doi: 10.3390/medicina56120633.
5
Role of Bcl-2 on drug resistance in breast cancer polyploidy-induced spindle poisons.Bcl-2在乳腺癌多倍体诱导的纺锤体毒素耐药中的作用。
Oncol Lett. 2020 Mar;19(3):1701-1710. doi: 10.3892/ol.2020.11256. Epub 2020 Jan 7.
6
Suppressive effects of anagrelide on cell cycle progression and the maturation of megakaryocyte progenitor cell lines in human induced pluripotent stem cells.阿那格雷对人诱导多能干细胞中巨核细胞祖细胞系的细胞周期进程和成熟的抑制作用。
Haematologica. 2020 May;105(5):e216-e220. doi: 10.3324/haematol.2018.214841. Epub 2019 Sep 5.
7
mutations and impact on clinical outcome: an analysis in 1,604 patients with newly diagnosed acute myeloid leukemia.突变及其对临床结局的影响:对1604例新诊断急性髓系白血病患者的分析
Haematologica. 2020 May;105(5):e228-e231. doi: 10.3324/haematol.2019.222323. Epub 2019 Aug 14.
8
Evaluation of Protein Kinase Inhibitors with PLK4 Cross-Over Potential in a Pre-Clinical Model of Cancer.评估在癌症临床前模型中具有 PLK4 交叉潜能的蛋白激酶抑制剂。
Int J Mol Sci. 2019 Apr 29;20(9):2112. doi: 10.3390/ijms20092112.
Arch Immunol Ther Exp (Warsz). 2016 Aug;64(4):259-78. doi: 10.1007/s00005-015-0382-6. Epub 2016 Jan 2.
4
Aurora B Overexpression Causes Aneuploidy and p21Cip1 Repression during Tumor Development.极光激酶B过表达在肿瘤发生过程中导致非整倍体及p21Cip1抑制。
Mol Cell Biol. 2015 Oct;35(20):3566-78. doi: 10.1128/MCB.01286-14. Epub 2015 Aug 3.
5
Dynamic transcription factor activity profiles reveal key regulatory interactions during megakaryocytic and erythroid differentiation.动态转录因子活性谱揭示巨核细胞和红细胞分化过程中的关键调控相互作用。
Biotechnol Bioeng. 2014 Oct;111(10):2082-94. doi: 10.1002/bit.25262. Epub 2014 Jul 14.
6
Src family kinases promote silencing of ATR-Chk1 signaling in termination of DNA damage checkpoint.Src 家族激酶促进 ATR-Chk1 信号沉默,以终止 DNA 损伤检查点。
J Biol Chem. 2014 May 2;289(18):12313-29. doi: 10.1074/jbc.M113.533752. Epub 2014 Mar 14.
7
Three-stage ex vivo expansion of high-ploidy megakaryocytic cells: toward large-scale platelet production.三阶段体外扩增高倍体巨核细胞:实现大规模血小板生产。
Tissue Eng Part A. 2013 Apr;19(7-8):998-1014. doi: 10.1089/ten.TEA.2011.0111. Epub 2013 Jan 14.
8
Optimizing megakaryocyte polyploidization by targeting multiple pathways of cytokinesis.通过靶向细胞分裂的多个途径优化巨核细胞多倍体化。
Transfusion. 2012 Nov;52(11):2406-13. doi: 10.1111/j.1537-2995.2012.03711.x. Epub 2012 May 21.
9
A journey to produce platelets in vitro.体外生成血小板的旅程。
Transfusion. 2011 Nov;51 Suppl 4:169S-176S. doi: 10.1111/j.1537-2995.2011.03380.x.
10
Plasmodium induced by SU6656, an Src family kinase inhibitor, is accompanied by a contractile ring defect.Src家族激酶抑制剂SU6656诱导的疟原虫伴有收缩环缺陷。
Cell Biochem Funct. 2012 Jan;30(1):33-40. doi: 10.1002/cbf.1814. Epub 2011 Oct 27.